Las Vegas - The FDA on Jan. 2 cleared Berlex Laboratories Inc. to market Finacea (azelaic acid 15 percent) gel for the treatment of rosacea.
SLIDESHOW: Drug and Treatment Spotlights at Maui Derm NP+PA Fall
The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis
Spotlighting Advances in Atopic Dermatitis Research and Prevention Strategies
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
A Hairy Q&A With Jerry Shapiro, MD
The Importance of Timing With Live Vaccinations in Pediatric Atopic Dermatitis